Ikena Oncology, Inc.IKNANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank57
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-4.00%
↓ 111% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
35.30%
Historical baseline
PeriodValue
2025-4.00%
202442.31%
2023-7.60%
2022-23.00%
2021-59.29%
2020-178.92%
2019512.88%
20180.00%